• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期患者报告结局的比较

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.

作者信息

Nishimura Koichi, Nakamura Saya, Kusunose Masaaki, Nakayasu Kazuhito, Sanda Ryo, Hasegawa Yoshinori, Oga Toru

机构信息

Department of Respiratory Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

BMJ Open Respir Res. 2018 Oct 9;5(1):e000305. doi: 10.1136/bmjresp-2018-000305. eCollection 2018.

DOI:10.1136/bmjresp-2018-000305
PMID:30397483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6203045/
Abstract

INTRODUCTION

The aim of this study was to investigate which patient-reported outcome measure was the best during the recovery phase from severe exacerbation of chronic obstructive pulmonary disease (COPD).

METHODS

The Exacerbations of Chronic Pulmonary Disease Tool (EXACT), the COPD Assessment Test (CAT), the St George's Respiratory Questionnaire (SGRQ), the Dyspnoea-12 (D-12) and the Hyland Scale (global scale) were recorded every week for the first month and at 2 and 3 months in 33 hospitalised subjects with acute exacerbation of COPD (AECOPD).

RESULTS

On the day of admission (day 1), the internal consistency of the EXACT total score was high (Cronbach's alpha coefficient=0.89). The EXACT total, CAT, SGRQ total and Hyland Scale scores obtained on day 1 appeared to be normally distributed. Neither floor nor ceiling effects were observed for the EXACT total and SGRQ total scores. The EXACT total score improved from 50.5±12.4 to 32.5±14.3, and the CAT score also improved from 24.4±8.5 to 13.5±8.4 during the first 2 weeks, and the effect sizes (ES) of the EXACT total and CAT score were -1.40 and -1.36, respectively. The SGRQ, Hyland Scale and D-12 were less responsive, with ES of -0.59, 0.96 and -0.90, respectively.

DISCUSSION

The EXACT total and CAT scores are shown to be more responsive measures during the recovery phase from severe exacerbation. Considering the conceptual framework, it is recommended that the EXACT total score may be the best measure during the recovery phase from AECOPD. The reasons for the outstanding responsiveness of the CAT are still unknown.

摘要

引言

本研究旨在调查在慢性阻塞性肺疾病(COPD)严重加重后的恢复阶段,哪种患者报告的结局指标最佳。

方法

对33例因慢性阻塞性肺疾病急性加重(AECOPD)住院的患者,在第1个月每周记录慢性肺疾病加重工具(EXACT)、慢性阻塞性肺疾病评估测试(CAT)、圣乔治呼吸问卷(SGRQ)、呼吸困难12项问卷(D - 12)和海兰德量表(整体量表),并在第2个月和第3个月进行记录。

结果

入院当天(第1天),EXACT总分的内部一致性较高(克朗巴哈α系数 = 0.89)。第1天获得的EXACT总分、CAT、SGRQ总分和海兰德量表分数似乎呈正态分布。EXACT总分和SGRQ总分均未观察到地板效应或天花板效应。在最初2周内,EXACT总分从50.5±12.4改善至32.5±14.3,CAT分数也从24.4±8.5改善至13.5±8.4,EXACT总分和CAT分数的效应量(ES)分别为 - 1.40和 - 1.36。SGRQ、海兰德量表和D - 12的反应性较低,ES分别为 - 0.59、0.96和 - 0.90。

讨论

EXACT总分和CAT分数在严重加重后的恢复阶段显示出更高的反应性。考虑到概念框架,建议EXACT总分可能是AECOPD恢复阶段的最佳指标。CAT反应性出色的原因尚不清楚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/3c0afe455440/bmjresp-2018-000305f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/305cdd76c06c/bmjresp-2018-000305f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/11329d9fea35/bmjresp-2018-000305f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/3c0afe455440/bmjresp-2018-000305f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/305cdd76c06c/bmjresp-2018-000305f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/11329d9fea35/bmjresp-2018-000305f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/6203045/3c0afe455440/bmjresp-2018-000305f03.jpg

相似文献

1
Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者报告结局的比较
BMJ Open Respir Res. 2018 Oct 9;5(1):e000305. doi: 10.1136/bmjresp-2018-000305. eCollection 2018.
2
Utility of the CAT in the therapy assessment of COPD exacerbations in China.CAT 在 COPD 加重期中国治疗评估中的作用。
BMC Pulm Med. 2014 Mar 11;14:42. doi: 10.1186/1471-2466-14-42.
3
The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?慢性阻塞性肺疾病评估测试和圣乔治呼吸问卷:它们在慢性阻塞性肺疾病患者中是否等效?
Int J Chron Obstruct Pulmon Dis. 2016 Jul 7;11:1543-51. doi: 10.2147/COPD.S104947. eCollection 2016.
4
Health status of COPD patients undergoing pulmonary rehabilitation: A comparative responsiveness of the CAT and SGRQ.COPD 患者肺康复治疗后的健康状况:CAT 和 SGRQ 的比较反应性。
Chron Respir Dis. 2017 Nov;14(4):352-359. doi: 10.1177/1479972317694622. Epub 2017 Mar 15.
5
Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?慢性阻塞性肺疾病患者的衰弱与患者报告结局:它们是独立的实体吗?
BMJ Open Respir Res. 2017 Jul 3;4(1):e000196. doi: 10.1136/bmjresp-2017-000196. eCollection 2017.
6
[Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者疾病严重程度及治疗疗效评估的不同评估系统比较]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jul 20;41(7):1119-1124. doi: 10.12122/j.issn.1673-4254.2021.07.23.
7
Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?对于慢性阻塞性肺疾病患者,面对面访谈和电话访谈在实施慢性阻塞性肺疾病评估测试(CAT)、功能性慢性疾病治疗功能评估-疲劳量表(FACIT-FS)和圣乔治呼吸问卷(SGRQ)时是等效的方式吗?
Front Rehabil Sci. 2021 Oct 25;2:729190. doi: 10.3389/fresc.2021.729190. eCollection 2021.
8
The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.圣乔治呼吸问卷对慢性支气管炎的定义可能比经典定义更能预测 COPD 加重。
Chest. 2019 Oct;156(4):685-695. doi: 10.1016/j.chest.2019.03.041. Epub 2019 May 15.
9
Comparison of Predictive Properties between Tools of Patient-Reported Outcomes: Risk Prediction for Three Future Events in Subjects with COPD.患者报告结局工具之间预测属性的比较:慢性阻塞性肺疾病患者三种未来事件的风险预测
Diagnostics (Basel). 2023 Jul 4;13(13):2269. doi: 10.3390/diagnostics13132269.
10
COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.用于测量特发性肺纤维化患者健康状况的慢性阻塞性肺疾病评估测试:一项横断面研究。
Respirology. 2017 May;22(4):721-727. doi: 10.1111/resp.12936. Epub 2016 Nov 9.

引用本文的文献

1
Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的早期检测与预测
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun.
2
Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations.使用慢性阻塞性肺疾病评估测试(COPD Assessment Test)分数的每周远程监测对健康状况进展进行为期1年的测量及其与慢性阻塞性肺疾病急性加重的关联
Chronic Obstr Pulm Dis. 2024 Mar 26;11(2):144-154. doi: 10.15326/jcopdf.2023.0415.
3

本文引用的文献

1
The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.症状定义的慢性阻塞性肺疾病急性加重恢复对健康状况和肺功能的短期影响。
Chronic Obstr Pulm Dis. 2018 Jan 24;5(1):27-37. doi: 10.15326/jcopdf.5.1.2017.0166.
2
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
3
Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.
慢性阻塞性肺疾病评估测试的临床开发与研究应用
Am J Respir Crit Care Med. 2020 May 1;201(9):1058-1067. doi: 10.1164/rccm.201907-1369PP.
医院招募患者和社区招募患者中使用情况及症状定义的慢性阻塞性肺疾病加重的发生率。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 2;11:2099-108. doi: 10.2147/COPD.S108720. eCollection 2016.
4
Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD.COPD 急性加重住院后生活质量的纵向变化。
BMJ Open Respir Res. 2015 Jan 15;2(1):e000069. doi: 10.1136/bmjresp-2014-000069. eCollection 2015.
5
Characterisation and impact of reported and unreported exacerbations: results from ATTAIN.报告和未报告恶化事件的特征及影响:来自 ATTAIN 的结果。
Eur Respir J. 2014 Nov;44(5):1156-65. doi: 10.1183/09031936.00038814. Epub 2014 Sep 18.
6
Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).使用慢性阻塞性肺病加重工具(EXACT)检测和严重程度分级 COPD 加重。
Eur Respir J. 2014 Mar;43(3):735-44. doi: 10.1183/09031936.00110913. Epub 2013 Aug 29.
7
How should we define and classify exacerbations in chronic obstructive pulmonary disease?我们应该如何定义和分类慢性阻塞性肺疾病的加重?
Expert Rev Respir Med. 2013 Apr;7(2 Suppl):33-41. doi: 10.1586/ers.13.16.
8
Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?CAT 问卷是否能敏感地反映严重 COPD 加重患者健康状况的变化?
COPD. 2012 Aug;9(5):492-8. doi: 10.3109/15412555.2012.692409. Epub 2012 Sep 7.
9
Development of the Japanese version of the COPD Assessment Test.慢性阻塞性肺疾病评估测试日语版的开发。
Respir Investig. 2012 Jun;50(2):34-9. doi: 10.1016/j.resinv.2012.05.003. Epub 2012 Jun 19.
10
Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.慢性阻塞性肺疾病评估测试在评估 COPD 加重严重程度中的作用。
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.